Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Rev Med Pharmacol Sci ; 18(12): 1762-9, 2014.
Article in English | MEDLINE | ID: mdl-24992620

ABSTRACT

OBJECTIVE: This study aims to observe the influence of 1,25-(OH)2D3 on airway inflammation and chemokine expression in asthmatic rats and to explore its significance in the treatment of asthma. MATERIALS AND METHODS: Wistar rats were randomly divided into a normal control group (N), an asthma group (A), a 1,25-(OH)2D3 group (VD), a budesonide group (P) and a 1,25-(OH)2D3 + budesonide treatment group (L). The acute asthma models were established through ovalbumin sensitisation and challenge. Lung tissues were stained with haematoxylin and eosin to observe pathologic changes, whereas an enzyme-linked immunosorbent assay was used to examine serum IgE, as well as the eosinophil chemoattractant protein (eotaxin) and interleukin-8 (IL-8) expression levels in bronchoalveolar lavage fluid and the serum. RESULTS: VD treatment partially reversed the characteristic pathological changes of airway inflammation. The IgE, eotaxin, and IL-8 expression levels in the VD group were significantly lower than those in the A group (p < 0.05) but remained higher than those in the control group (p < 0.05). CONCLUSIONS: 1,25-(OH)2D3 reduces airway inflammation, airway hyperresponsiveness and airway remodeling by partially inhibiting chemokine production during airway inflammation, and 1,25-(OH)2D3 synergises with hormone therapy.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Asthma/drug therapy , Calcitriol/therapeutic use , Vitamins/therapeutic use , Allergens/immunology , Animals , Anti-Inflammatory Agents/pharmacology , Asthma/blood , Asthma/immunology , Asthma/pathology , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Calcitriol/pharmacology , Cell Count , Chemokine CCL11/blood , Female , Immunoglobulin E/blood , Immunoglobulin E/immunology , Interleukin-8/blood , Lung/drug effects , Lung/immunology , Lung/pathology , Ovalbumin/immunology , Rats, Wistar , Vitamins/pharmacology
2.
Genet Mol Res ; 12(3): 3305-13, 2013 Sep 03.
Article in English | MEDLINE | ID: mdl-24065672

ABSTRACT

Small GTPases play a critical role in the regulation of a range of cellular processes including growth, differentiation, and intracellular transportation. The cDNA encoding a small GTPase, designated as HbGTPase1, was isolated from Hevea brasiliensis. HbGTPase1 was 882 bp long containing a 612-bp open reading frame encoding a putative protein of 203 amino acids, flanked by an 83-bp 5'-untranslated region (UTR) and a 187-bp 3'-UTR. The predicted molecular mass of HbGTPase1 is 22.62 kDa, with an isoelectric point of 5.06. The HbGTPase1 protein was predicted to possess the conserved functional regions of the small GTPase superfamily of proteins. Quantitative polymerase chain reaction analysis revealed that HbGTPase1 was constitutively expressed in all tissues tested. HbGTPase1 transcripts accumulated at relatively low levels in the flower, latex, and leaves, while HbGTPase1 transcripts accumulated at relatively high levels in bark. Transcription of HbGTPase1 in the latex was induced by jasmonate.


Subject(s)
Cloning, Molecular , Hevea/genetics , Monomeric GTP-Binding Proteins/genetics , Amino Acid Sequence , DNA, Complementary/genetics , Gene Expression Regulation, Plant , Latex/chemistry , Monomeric GTP-Binding Proteins/isolation & purification
3.
Biomed Mater ; 6(4): 045002, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21613722

ABSTRACT

Cardiac tissue engineering holds great promise for the treatment of myocardial infarction. However, insufficient cell migration into the scaffolds used and inflammatory reactions due to scaffold biodegradation remain as issues to be addressed. Engineered heart tissue (EHT) grafts fabricated by means of a cell encapsulation technique provide cells with a tissue-like environment, thereby potentially enhancing cellular processes such as migration, proliferation, and differentiation, and tissue regeneration. This paper presents a study on the fabrication and characterization of EHT grafts from novel alginate/collagen composite microbeads by means of cell encapsulation. Specifically, the microbeads were fabricated from alginate and collagen by barium ion cross-linking, with neonatal rat cardiomyocytes encapsulated in the composite microbeads during the fabrication of the EHT grafts. To evaluate the suitablity of these EHT grafts for heart muscle repair, the growth of cardiac cells in the microbeads was examined by means of confocal microscopy and staining with DAPI and F-actin. The EHT grafts were analyzed by scanning electron microscopy and transmission electron microscopy, and the contractile function of the EHT grafts monitored using a digital video camera at different time points. The results show the proliferation of cardiac cells in the microbeads and formation of interconnected multilayer heart-like tissues, the presence of well-organized and dense cell structures, the presence of intercalated discs and spaced Z lines, and the spontaneous synchronized contractility of EHT grafts (at a rate of 20-30 beats min(-1) after two weeks in culture). Taken together, these observations demonstrate that the novel alginate/collagen composite microbeads can provide a tissue-like microenvironment for cardiomyocytes that is suitable for fabricating native heart-like tissues.


Subject(s)
Alginates/chemistry , Barium/chemistry , Collagen/chemistry , Tissue Engineering/methods , Actins/metabolism , Animals , Biocompatible Materials/chemistry , Cross-Linking Reagents/chemistry , Heart/physiology , Heart Ventricles/pathology , Inflammation , Microscopy, Electron, Scanning/methods , Microscopy, Electron, Transmission/methods , Microspheres , Myocytes, Cardiac/cytology , Rats , Rats, Wistar
4.
Biomed Mater ; 2(3): S142-6, 2007 Sep.
Article in English | MEDLINE | ID: mdl-18458459

ABSTRACT

A biocompatible hydrogel of hyaluronic acid with the neurite-promoting peptide sequence of IKVAV was synthesized. The characterization of the hydrogel shows an open porous structure and a large surface area available for cell interaction. Its ability to promote tissue repair and axonal regeneration in the lesioned rat cerebrum is also evaluated. After implantation, the polymer hydrogel repaired the tissue defect and formed a permissive interface with the host tissue. Axonal growth occurred within the microstructure of the network. Within 6 weeks the polymer implant was invaded by host-derived tissue, glial cells, blood vessels and axons. Such a hydrogel matrix showed the properties of neuron conduction. It has the potential to repair tissue defects in the central nervous system by promoting the formation of a tissue matrix and axonal growth by replacing the lost tissue.


Subject(s)
Axons/pathology , Brain Injuries/pathology , Brain Injuries/therapy , Guided Tissue Regeneration/methods , Hyaluronic Acid/therapeutic use , Laminin/therapeutic use , Nerve Regeneration/physiology , Peptide Fragments/therapeutic use , Animals , Axons/physiology , Hyaluronic Acid/chemistry , Hydrogels/chemistry , Hydrogels/therapeutic use , Laminin/chemistry , Materials Testing , Peptide Fragments/chemistry , Rats , Rats, Sprague-Dawley , Treatment Outcome
5.
J Mater Sci Mater Med ; 17(12): 1393-401, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17143772

ABSTRACT

In this paper, hyaluronic acid hydrogels with open porous structure have been developed for scaffold of brain tissue engineering. A short peptide sequence of arginine-glycine-aspartic acid (RGD) was immobilized on the backbone of the hydrogels. Both unmodified hydrogels and those modified with RGD were implanted into the defects of cortex in rats and evaluated for their ability to improve tissue reconstruction. After 6 and 12 weeks, sections of brains were processed for DAB and Glees staining. They were also labeled with GFAP and ED1 antibodies, and observed under the SEM for ultrastructral examination. After implanting into the lesion of cortex, the porous hydrogels functioned as a scaffold to support cells infiltration and angiogenesis, simultaneously inhibiting the formation of glial scar. In addition, HA hydrogels modified with RGD were able to promote neurites extension. Our experiments showed that the hyaluronic acid-RGD hydrogel provided a structural, three-dimensional continuity across the defect and favoured reorganization of local wound-repair cells, angiogenesis and axonal growth into the hydrogel scaffold, while there was little evidence of axons regeneration in unmodified hydrogel.


Subject(s)
Brain Injuries/metabolism , Brain Injuries/surgery , Hyaluronic Acid/administration & dosage , Hydrogels/administration & dosage , Oligopeptides/administration & dosage , Tissue Engineering , Absorbable Implants , Animals , Brain Injuries/pathology , Cell Movement/physiology , Female , Hyaluronic Acid/therapeutic use , Hyaluronic Acid/ultrastructure , Hydrogels/therapeutic use , Microscopy, Electron, Scanning , Oligopeptides/therapeutic use , Porosity , Rats , Rats, Sprague-Dawley
6.
Tissue Eng ; 11(3-4): 513-25, 2005.
Article in English | MEDLINE | ID: mdl-15869430

ABSTRACT

Brain tissue engineering in the postinjury brain represents a promising option for cellular replacement and rescue, providing a cell scaffold for either transplanted or resident cells. In this article, a hyaluronic acid (HA)-poly-D-lysine (PDL) copolymer hydrogel with an open porous structure and viscoelastic properties similar to neural tissue has been developed for brain tissue engineering. The chemicophysical properties of the hydrogel with HA:PDL ratios of 10:1, 5:1, and 4:1 were investigated by scanning electron microscopy (SEM) and X-ray photoelectron spectrometry. Neural cells cultured in the hydrogel were studied by phase-contrast microscope and SEM. The incorporation of PDL peptides into the HA-PDL hydrogel allowed for the modulation of neuronal cell adhesion and neural network formation. Macrophages and multinucleated foreign body giant cells found at the site of implantation of the hydrogel in the rat brain within the first weeks postimplantation decreased in numbers after 6 weeks, consistent with the host response to inert implants in numerous tissues. Of importance was the infiltration of the hydrogel by glial fibrillary acidic protein-positive cells-reactive astrocytes-by immunohistochemistry and the contiguity between the hydrogel and the surrounding tissue demonstrated by SEM. These findings indicated the compatibility of this hydrogel with brain tissue. Collectively, the results demonstrate the promise of an HA-PDL hydrogel as a scaffold material for the repair of defects in the brain.


Subject(s)
Brain Injuries/pathology , Brain Injuries/therapy , Hyaluronic Acid/chemistry , Neurons/cytology , Polylysine/chemistry , Tissue Engineering/methods , Animals , Animals, Newborn , Biocompatible Materials/chemistry , Cell Proliferation , Cells, Cultured , Guided Tissue Regeneration/methods , Hydrogels/chemistry , Materials Testing , Molecular Conformation , Nerve Regeneration/physiology , Neurons/physiology , Porosity , Rats , Rats, Sprague-Dawley , Rats, Wistar , Surface Properties , Treatment Outcome
7.
J Control Release ; 102(1): 13-22, 2005 Jan 20.
Article in English | MEDLINE | ID: mdl-15653130

ABSTRACT

Nogo-66 and NgR are important receptors inhibiting neuronal regeneration and therefore are targets for treating CNS injury. Antagonists of this receptor including blocking antibodies are potential therapeutic agents for CNS axonal injuries such as spinal cord and brain trauma. A new antibody (IgG) releasing system has been developed by covalently attaching IgG to the biodegradable hyaluronic acid (HA) hydrogel via the hydrolytically unstable hydrazone linkage, aiming to deliver the antibody of CNS regeneration inhibitors to the injured brain. In this paper we describe the synthesis, physico-chemical characteristics and test results of biological activity of antibody released from hyluronic acid hydrogel. To form the conjugates the antibody is attached to the polymer backbone using a condensation reaction between aldehyde group of the antibody and hydrazide group of the HA hydrogel. Furthermore, pH sensitive linkage-hydrozone has been formed between hydrogel and antibody. The amount of conjugated antibodies can reach 135 microg antibody/mg hydrogel in the dry state. At low pH, the antibodies released quite fast. However, the antibodies released much slower in neutral and alkaline environment. The bioactivity of antibody released from hydrogel was retained as demonstrated by indirect immunofluorescence technique.


Subject(s)
Antibodies/administration & dosage , Brain Injuries/drug therapy , Drug Delivery Systems/methods , Hyaluronic Acid/administration & dosage , Hydrogels/administration & dosage , Myelin Proteins/administration & dosage , Myelin Proteins/immunology , Receptors, Cell Surface/administration & dosage , Receptors, Cell Surface/immunology , Amino Acid Sequence , Animals , Antibodies/metabolism , Brain Injuries/metabolism , GPI-Linked Proteins , Hyaluronic Acid/chemistry , Hyaluronic Acid/pharmacokinetics , Hydrogels/chemistry , Hydrogels/pharmacokinetics , Molecular Sequence Data , Myelin Proteins/pharmacokinetics , Nogo Receptor 1 , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...